Biodexa Announces Allowance of U.S. Patent Covering Tolimidone

Biodexa Pharmaceuticals PLCBiodexa Announces Allowance of U.S. Patent Covering TolimidoneBiodexa plans to initiate a Phase 2 clinical program of t...

Related Keywords

United Kingdom ,United States ,Laine Yonker ,Bukwang Pharmaceutical Co Ltd ,Melior Pharmaceuticals Inc ,Exchange Commission ,Nasdaq ,Pfizer ,Biodexa Pharmaceuticals ,Pfizer Inc ,Trademark Office ,Company Nasdaq ,Edison Group Us Investor Relations ,Announces Allowance ,Pancreatic Cell ,Melior Pharmaceuticals ,Private Securities Litigation Reform Act ,United States Securities ,